查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
全球药品冷链市场：按初级包装类型、二级包装类型、使用类型和主要地区：过去趋势（2019-2022年）以及估计和预测（2023-2035）
市场调查报告书
商品编码
1398318

全球药品冷链市场：按初级包装类型、二级包装类型、使用类型和主要地区：过去趋势（2019-2022年）以及估计和预测（2023-2035）

Cold Chain Market for Pharmaceuticals: Distribution by Type of Primary Packaging, Type of Secondary Packaging, Type of Usability and Key Geographical Regions: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
出版日期: | 出版商: Roots Analysis | 英文 255 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

到 2023 年，全球冷链市场规模将达到 62 亿美元，在预测期内（2023-2035 年）复合年增长率为 3.7%。

冷链代表了一个由精确校准的程序和设备组成的复杂系统，专为储存和运输温度敏感物质而设计。 冷链依赖主动和被动热包装解决方案，包括冷链托运机、隔热容器、冷媒和数据记录器等监控设备。 广泛应用于食品、乳製品、化学、医药领域，其主要目的是延长保存期限，保护生鲜食品、疫苗、药品等易腐物品的品质和功效。 特别是，药品冷链可满足各种药品（包括生物製剂、COVID-19 疫苗和器官移植）的严格温度要求，确保其完整性和生存能力。 冷链监控的最新进展，特别是温度感测器和即时追踪设备的出现，透过允许在运输过程中进行连续监控，大大提高了该过程的效率。

然而，挑战仍然存在，特别是在药品储存和运输过程中的包装和温度控制方面。 在一些地区，包装和温度控制不当导致很大一部分药物失效。 设备故障或暴露在过热环境等不可预见的事件可能会破坏冷链并造成损坏或污染的风险。 为了应对这些挑战，行业利益相关者正在积极寻求混合解决方案。 这些创新方法将温度数据记录器整合到冷链货柜中，提高可视性并更有效地追踪药品运输。 这种整合代表了传统包装解决方案的一种有前途的替代方案。 由于该行业的持续努力，考虑到持续的进步和强劲的成长轨迹，预计药品冷链市场在预测期内将大幅扩张。

本报告对全球医药冷链市场进行了分析，包括市场的基本结构和最新情况、近期的重大资本交易和业务联盟、推动和抑制市场的主要因素以及整体市场。规模、按细分市场和地区划分的详细趋势以及主要公司的概况。

目录

第一章前言

第二章分析方法

第 3 章经济与其他专案特定考量

  • 分析概述
  • 市场动态

第 4 章执行摘要

第 5 章简介

  • 分析概述
  • 冷链包装概论
  • 冷链绩效时间表
  • 製药业的冷链解决方案
  • 冷链在製药业的应用
  • 当前问题与未来前景

第六章整体市场状况：冷链货柜/托运人提供者

  • 分析概述
  • 冷链货柜/托运商：整体市场情势

第 7 章整体市场情势：资料记录器提供者

  • 分析概述
  • 数据记录器提供者：整体市场情势
  • 依成立年份分析
  • 依公司规模分析
  • 依总部所在地（地区）分析
  • 依总部地点（国家）分析
  • 依产品类型分析
  • 依资料传输方式分析
  • 按取得的资料类型进行分析
  • 依监测药物类型分析
  • 依温度范围分析
  • 依产品类型和资料传输方式分析
  • 依照提供的产品类型和收集的资料类型进行分析

第 8 章竞争基准测试

  • 分析概述
  • 假设与研究方法
  • 冷链货柜/托运供应商的竞争基准
  • 结论

第九章公司简介

  • 分析概述
  • Cold Chain Technologies
  • Cryopak
  • CSafe
  • EMBALL'ISO
  • Intelsius
  • Nordic Cold Chain Solutions
  • Peli BioThermal
  • SEE
  • SOFRIGAM
  • Sonoco Thermosafe
  • Tempack
  • Other Leading Players

第 10 章商业伙伴/合作

  • 分析概述
  • 业务伙伴关係/合作模式
  • 药品冷链：业务伙伴关係/合作
  • 医药冷链：企业收购

第11章专利分析

  • 分析概述
  • 分析范围/方法
  • 药品冷链：专利分析
  • 医药冷链：专利基准分析
  • 专利评估分析

第 12 章监理建议与指引

  • 分析概述
  • 国际组织发布的监管指南
  • 国家主管机关发布的监理指南
  • 针对冷链每个步骤的建议
  • 监理机构比较分析

第 13 章未来趋势与未来成长机会

  • 分析概述
  • 互联冷链：关键工具与技术
  • 互联冷链：未来成长机会
  • 即时监控：连网冷链解决方案的应用

第 14 章市场影响分析：驱动因素、限制、机会、挑战

  • 分析概述
  • 市场驱动因素
  • 市场限制因素
  • 市场机会
  • 市场挑战
  • 结论

第十五章药品冷链市场

  • 分析概述
  • 假设与研究方法
  • 全球药品冷链市场：过去趋势（2019-2022）与预测（2023-2035）
  • 主要细分市场
  • 动态仪表板

第十六章药品冷链市场：依初级包装类型

  • 分析概述
  • 主要假设与研究方法
  • 小瓶：过去的趋势（2019-2022 年）与预测（2023-2035 年）
  • 安瓿：过去的趋势（2019-2022）与预测（2023-2035）
  • 预充式註射器：过去趋势（2019-2022 年）与预测（2023-2035 年）
  • 箱包：过去趋势（2019-2022 年）与预测（2023-2035 年）
  • 数据测量

第十七章药品冷链市场：依二次包装类型

  • 分析概述
  • 主要假设与研究方法
  • 冷箱：过去的趋势（2019-2022）与预测（2023-2035）
  • 疫苗带因者：过去的趋势（2019-2022）与预测（2023-2035）
  • 保温容器：过去趋势（2019-2022 年）与预测（2023-2035 年）
  • 数据测量

第 18 章药品冷链市场：依使用类型划分

  • 分析概述
  • 主要假设与研究方法
  • 可重复使用的货柜/托运商：过去的趋势（2019-2022 年）和预测（2023-2035 年）
  • 一次性容器/托运商：过去趋势（2019-2022 年）和预测（2023-2035 年）

第十九章医药冷链市场：依主要地区

  • 分析概述
  • 主要假设与研究方法
  • 北美：过去趋势（2019-2022 年）与预测（2023-2035 年）
  • 欧洲：过去趋势（2019-2022 年）与预测（2023-2035 年）
  • 亚太地区：过去趋势（2019-2022 年）与预测（2023-2035 年）
  • 中东与北美：过去趋势（2019-2022 年）与预测（2023-2035 年）
  • 拉丁美洲：过去趋势（2019-2022 年）与预测（2023-2035 年）
  • 其他地区（世界各地）：过去趋势（2019-2022 年）和预测（2023-2035 年）
  • 数据测量

第 20 章结论

第 21 章管理见解

  • 分析概述
  • EMBALL'ISO
  • Tower Cold Chain

第 22 章附录 1：表格资料

第23章附录2：公司与组织名单

简介目录
Product Code: RA100459

The global cold chain market is valued at USD 6.2 billion in 2023 growing at a CAGR of 3.7% during the forecast period 2023-2035.

The cold chain represents a sophisticated system of precisely coordinated steps and equipment designed for the storage and transportation of temperature-sensitive materials. It relies on both active and passive thermal packaging solutions, encompassing cold chain shippers, insulated containers, refrigerants, and monitoring devices like data loggers. Widely applied in food, dairy, chemical, and pharmaceutical sectors, its primary goal is to extend the shelf life of perishable items such as fresh produce, vaccines, and pharmaceuticals, safeguarding their quality and efficacy. Notably, the pharmaceutical cold chain caters to the stringent temperature requirements of various pharmaceutical products, including biologics, COVID vaccines, and organ transplants, ensuring their integrity and viability. Recent advancements in cold chain monitoring, particularly the emergence of temperature sensors and real-time tracking devices, have significantly enhanced the efficiency of this process by enabling continuous monitoring during shipment.

Nevertheless, challenges persist, especially concerning packaging and temperature control during pharmaceutical storage and transportation. Inadequate packaging and temperature control contribute to a substantial percentage of drugs losing their effectiveness in some regions. Unforeseen issues like equipment failures or exposure to excessive heat can disrupt the cold chain, posing risks of damage or contamination. To address these challenges, industry stakeholders are actively pursuing hybrid solutions. These innovative approaches integrate temperature data loggers into cold chain containers, enhancing visibility and enabling more efficient tracking of pharmaceutical shipments. This integration stands as a promising alternative to conventional packaging solutions. Considering the ongoing advancements and the robust growth trajectory of the pharmaceutical cold chain market, driven by continuous industry efforts, substantial expansion is anticipated in the forecasted period.

Key Market Segments

Type of Primary Packaging

  • Vials
  • Ampoules
  • Pre-filled Syringes
  • Bags

Type of Secondary Packaging

  • Cold Boxes
  • Vaccine Carriers
  • Insulated Containers

Type of Usability

  • Reusable
  • Single use

Key Geographical Regions:

  • North America
  • Europe
  • Asia-Pacific
  • Middle East and North Africa
  • Latin America
  • Rest of the World

Research Coverage:

  • The report studies the cold chain market for pharmaceuticals based on type of primary packaging, type of secondary packaging, type of usability and key geographical regions
  • The report analyzes factors (such as drivers, restraints, opportunities, and challenges) affecting the market growth
  • The report assesses the potential advantages and obstacles within the market for those involved and offers information on the competitive environment for top players in the market.
  • The report forecasts the revenue of market segments with respect to six major regions
  • Detailed insights into the research approach adopted, encompassing methodologies, assumptions, and quality control measures employed to ensure precision and reliability of findings.
  • Historical trends, currency fluctuations, foreign exchange impacts, and measurements related to recession and inflation affecting the overall cold chain market for pharmaceuticals.
  • A high-level overview of current status and probable future evolution of the cold chain market in pharmaceuticals over the mid-to-long term.
  • Explaining cold chain packaging, its historical timeline, various packaging solutions, applications in the pharmaceutical industry, existing challenges, and future perspectives.
  • Comprehensive evaluation of 72 cold chain container/shipper providers based on parameters like establishment year, company size, headquarters location, product types, materials used, temperature storage, and services offered.
  • Detailed analysis of 70 data logger providers considering establishment year, company size, headquarters location, product types, data transmission modes, monitored parameters, and temperature ranges.
  • Comparison of key focus areas among cold chain container/shipper providers in North America, Europe, and Asia-Pacific, facilitating stakeholders to identify competitive advantages.
  • Detailed profiles of key cold chain container/shipper providers, highlighting company overview, product and service portfolios, recent developments, future outlook, and profiles of leading hybrid solution providers.
  • Examination of partnerships, collaborations, mergers, and acquisitions among stakeholders since 2019, including details on partnership types, applications, geography, and active players in the industry.
  • In-depth exploration of patents filed or granted since 2019, covering types, publication and application years, organizations, jurisdictions, focus areas, leading industry players, benchmarking, and valuation analysis.
  • Detailed discussion on regulatory guidelines issued by international and regional authorities, providing recommendations for different stages of the cold chain process along with a comparative analysis of regulatory bodies.
  • Examination of emerging trends, growth opportunities, technological advancements (AI, AR, IoT, etc.), real-time monitoring, integration methods, associated benefits, and cost efficiencies in the cold chain pharmaceutical industry.
  • Analysis of factors influencing the growth of the cold chain market for pharmaceuticals, including drivers, restraints, opportunities, and challenges.

Key Benefits of Buying this Report:

  • The report offers market leaders and newcomers valuable insights into revenue estimations for both the overall market and its sub-segments.
  • Stakeholders can utilize the report to enhance their understanding of the competitive landscape, allowing for improved business positioning and more effective go-to-market strategies.
  • The report provides stakeholders with a pulse on the cold chain market for pharmaceuticals, furnishing them with essential information on significant market drivers, barriers, opportunities, and challenges.

Key Market Companies

  • Cold Chain Technologies
  • Cryopak
  • CSafe

EMBALL'ISO

  • Intelsius
  • Nordic Cold Chain Solutions
  • Peli BioThermal

SEE

SOFRIGAM

  • Sonoco Thermosafe
  • Tempack

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Cold Chain Market for Pharmaceuticals
  • 1.2. Key Market Insights
  • 1.3. Scope of the Report
  • 1.4. Research Methodology
  • 1.5. Frequently Asked Questions
  • 1.6. Chapter Outlines

2. RESEARCH METHODOLOGY

  • 2.1. Chapter Overview
  • 2.2. Research Assumptions
  • 2.3. Project Methodology
  • 2.4. Forecast Methodology
  • 2.5. Robust Quality Control
  • 2.6. Key Market Segmentations
  • 2.7. Key Considerations
    • 2.7.1. Demographics
    • 2.7.2. Economic Factors
    • 2.7.3. Government Regulations
    • 2.7.4. Supply Chain
    • 2.7.5. COVID Impact / Related Factors
    • 2.7.6. Market Access
    • 2.7.7. Healthcare Policies
    • 2.7.8. Industry Consolidation

3. ECONOMIC AND OTHER PROJECT SPECIFIC CONSIDERATIONS

  • 3.1. Chapter Overview
  • 3.2. Market Dynamics
    • 3.2.1. Time Period
      • 3.2.1.1. Historical Trends
      • 3.2.1.2. Current and Forecasted Estimates
    • 3.2.2. Currency Coverage
      • 3.2.2.1. Overview of Major Currencies Affecting the Market
      • 3.2.2.2. Impact of Currency Fluctuations on the Industry
    • 3.2.3. Foreign Exchange Impact
      • 3.2.3.1. Evaluation of Foreign Exchange Rates and Their Impact on Market
      • 3.2.3.2. Strategies for Mitigating Foreign Exchange Risk
    • 3.2.4. Recession
      • 3.2.4.1. Historical Analysis of Past Recessions and Lessons Learnt
      • 3.2.4.2. Assessment of Current Economic Conditions and Potential Impact on the Market
    • 3.2.5. Inflation
      • 3.2.5.1. Measurement and Analysis of Inflationary Pressures in the Economy
      • 3.2.5.2. Potential Impact of Inflation on the Market Evolution

4. EXECUTIVE SUMMARY

5. INTRODUCTION

  • 5.1. Chapter Overview
  • 5.2. Introduction to Cold Chain Packaging
  • 5.3. Historical Timeline of Cold Chain
  • 5.4. Cold Chain Solutions for Pharmaceutical Industry
    • 5.4.1. Cold Chain Packaging Solutions: Containers and Shippers
      • 5.4.1.1. Active Cold Chain Packaging Solutions
      • 5.4.1.2. Passive Cold Chain Packaging Solutions
      • 5.4.1.3. Insulated Cold Chain Packaging Solutions
    • 5.4.2. Cold Chain Monitoring Solutions: Data Loggers
      • 5.4.2.1. Data Loggers
      • 5.4.2.2. Indicators
  • 5.5. Applications of Cold Chain in Pharmaceutical Industry
  • 5.6. Current Challenges and Future Perspectives

6. OVERALL MARKET LANDSCAPE: COLD CHAIN CONTAINER / SHIPPER PROVIDERS

  • 6.1. Chapter Overview
  • 6.2. Cold Chain Container / Shipper Providers: Overall Market Landscape
    • 6.2.1. Analysis by Year of Establishment
    • 6.2.2. Analysis by Company Size
    • 6.2.3. Analysis by Location of Headquarters (Region)
    • 6.2.4. Analysis by Location of Headquarters (Country)
    • 6.2.5. Analysis by Type of Cold Chain Solution
    • 6.2.6. Analysis by Type of Product Offered
    • 6.2.7. Analysis by Type of Product Material
    • 6.2.8. Analysis by Type of Product Packaged
    • 6.2.9. Analysis by Storage Temperature
    • 6.2.10. Analysis by Type of Service Offered
    • 6.2.11. Analysis by Company Size and Type of Service Offered

7. OVERALL MARKET LANDSCAPE: DATA LOGGER PROVIDERS

  • 7.1. Chapter Overview
  • 7.2. Data Logger Providers: Overall Market Landscape
  • 7.3. Analysis by Year of Establishment
  • 7.4. Analysis by Company Size
  • 7.5. Analysis by Location of Headquarters (Region)
  • 7.6. Analysis by Location of Headquarters (Country)
  • 7.7. Analysis by Type of Product Offered
  • 7.8. Analysis by Mode of Data Transmission
  • 7.9. Analysis by Type of Data Captured
  • 7.10. Analysis by Type of Pharmaceutical Monitored
  • 7.11. Analysis by Temperature Range
  • 7.12. Analysis by Type of Product Offered and Mode of Data Transmission
  • 7.13. Analysis by Type of Product Offered and Type of Data Captured

8. COMPETITIVE BENCHMARKING

  • 8.1. Chapter Overview
  • 8.2. Assumptions and Methodology
  • 8.3. Competitive Benchmarking of Cold Chain Container / Shipper Providers
    • 8.3.1. Competitive Benchmarking: Players based in North America (Peer Group I)
    • 8.3.2. Competitive Benchmarking: Players based in Europe (Peer Group II)
    • 8.3.3. Competitive Benchmarking: Large Players based in Asia-Pacific and RoW (Peer Group III)
  • 8.4. Concluding Remarks

9. COMPANY PROFILES

  • 9.1. Chapter Overview
  • 9.2. Cold Chain Technologies
    • 9.2.1. Company Overview
    • 9.2.2. Product Portfolio
    • 9.2.3. Service Portfolio
    • 9.2.4. Recent Developments and Future Outlook
  • 9.3. Cryopak
    • 9.3.1. Company Overview
    • 9.3.2. Product Portfolio
    • 9.3.3. Service Portfolio
    • 9.3.4. Recent Developments and Future Outlook
  • 9.4. CSafe
    • 9.4.1. Company Overview
    • 9.4.2. Product Portfolio
    • 9.4.3. Service Portfolio
    • 9.4.4. Recent Developments and Future Outlook
  • 9.5. EMBALL'ISO
    • 9.5.1. Company Overview
    • 9.5.2. Product Portfolio
    • 9.5.3. Service Portfolio
    • 9.5.4. Recent Developments and Future Outlook
  • 9.6. Intelsius
    • 9.6.1. Company Overview
    • 9.6.2. Product Portfolio
    • 9.6.3. Service Portfolio
    • 9.6.4. Recent Developments and Future Outlook
  • 9.7. Nordic Cold Chain Solutions
    • 9.7.1. Company Overview
    • 9.7.2. Product Portfolio
    • 9.7.3. Service Portfolio
    • 9.7.4. Recent Developments and Future Outlook
  • 9.8. Peli BioThermal
    • 9.8.1. Company Overview
    • 9.8.2. Product Portfolio
    • 9.8.3. Service Portfolio
    • 9.8.4. Recent Developments and Future Outlook
  • 9.9. SEE
    • 9.9.1. Company Overview
    • 9.9.2. Product Portfolio
    • 9.9.3. Service Portfolio
    • 9.9.4. Recent Developments and Future Outlook
  • 9.10. SOFRIGAM
    • 9.10.1. Company Overview
    • 9.10.2. Product Portfolio
    • 9.10.3. Service Portfolio
    • 9.10.4. Recent Developments and Future Outlook
  • 9.11. Sonoco Thermosafe
    • 9.11.1. Company Overview
    • 9.11.2. Product Portfolio
    • 9.11.3. Service Portfolio
    • 9.11.4. Recent Developments and Future Outlook
  • 9.12. Tempack
    • 9.12.1. Company Overview
    • 9.12.2. Product Portfolio
    • 9.12.3. Service Portfolio
    • 9.12.4. Recent Developments and Future Outlook
  • 9.13. Other Leading Players
    • 9.13.1. Almac
    • 9.13.2. B Medical Systems
    • 9.13.3. BioLife Solutions
    • 9.13.4. CRS Mobile Cold Storage
    • 9.13.5. Desert Valley Tech
    • 9.13.6. Dubai Instruments
    • 9.13.7. Envirotainer
    • 9.13.8. Global Cold Chain Solutions (Headquartered in Australia)
    • 9.13.9. Global Cold Chain Solutions (Headquartered in Singapore)
    • 9.13.10. Klinge
    • 9.13.11. Krautz-temax
    • 9.13.12. Meds2go
    • 9.13.13. phasetwo
    • 9.13.14. Polar Tech Industries
    • 9.13.15. Skycell
    • 9.13.16. UPS Healthcare

10. PARTNERSHIPS AND COLLABORATIONS

  • 10.1. Chapter Overview
  • 10.2. Partnership Models
  • 10.3. Cold Chain for Pharmaceuticals: Partnerships and Collaborations
    • 10.3.1. Analysis by Year of Partnership
    • 10.3.2. Analysis by Type of Partnership
    • 10.3.3. Analysis by Year and Type of Partnership
    • 10.3.4. Analysis by Application Area
    • 10.3.5. Analysis by Type of Product / Technology
    • 10.3.6. Analysis by Geography
      • 10.3.6.1. Local and International Agreements
      • 10.3.6.2. Intercontinental and Intracontinental Agreements
    • 10.3.7 Most Active Players: Analysis by Number of Partnerships
  • 10.4. Cold Chain for Pharmaceuticals: Acquisitions
    • 10.4.1. Analysis by Year of Acquisition
    • 10.4.2. Analysis by Type of Acquisition
    • 10.4.2. Analysis by Year and Type of Acquisition
    • 10.4.3. Analysis by Application Area
    • 10.4.4. Analysis by Type of Product / Technology
    • 10.4.5. Analysis by Geography
      • 10.4.5.1. Local and International Agreements
      • 10.4.5.2. Intercontinental and Intracontinental Agreements
    • 10.4.6. Ownership Change Matrix
    • 10.4.7. Analysis by Key Value Drivers

11. PATENT ANALYSIS

  • 11.1. Chapter Overview
  • 11.2. Scope and Methodology
  • 11.3. Cold Chain for Pharmaceuticals: Patent Analysis
    • 11.3.1. Analysis by Type of Patent
    • 11.3.2. Analysis by Publication Year
    • 11.3.3. Analysis by Type of Patent and Publication Year
    • 11.3.4. Analysis by Application Year
    • 11.3.5. Analysis by Type of Organization
    • 11.3.6. Analysis by Patent Jurisdiction
    • 11.3.7. Analysis by CPC Symbols
    • 11.3.8. Analysis by Emerging Focus Area
    • 11.3.9. Leading Industry Players: Analysis by Number of Patents
  • 11.4. Cold Chain for Pharmaceuticals: Patent Benchmarking Analysis
    • 11.4.1. Analysis by Patent Characteristics
      • 11.4.1.1. Cold Chain Technologies and Ember LifeSciences
      • 11.4.1.2. Other Leading Patent Assignees
  • 11.5. Patent Valuation Analysis

12. REGULATORY RECOMMENDATIONS AND GUIDELINES

  • 12.1. Chapter Overview
  • 12.2. Regulatory Guidelines Issued by International Authorities
    • 12.2.1. World Health Organization (WHO)
    • 12.2.2. International Air Transport Association (IATA)
    • 12.2.3. International Safe Transit Association (ISTA)
  • 12.3. Regulatory Guidelines Issued by Regional Authorities
    • 12.3.1. Regulatory Guidelines for Cold Chain Management in the US
      • 12.3.1.1. United States Food and Drug Administration (USFDA)
    • 12.3.2. United States Pharmacopeia (USP)
    • 12.3.3. Regulatory Guidelines for Cold Chain Management in Canada
      • 12.3.3.1. Health Canada
    • 12.3.4. Regulatory Guidelines for Cold Chain Management in Europe
      • 12.3.4.1. European Medicine Agency
  • 12.4. Recommendations for Different Steps of Cold Chain
  • 12.5. Comparative Analysis of Regulatory Authorities

13. UPCOMING TRENDS AND FUTURE GROWTH OPPORTUNITIES

  • 13.1. Chapter Overview
  • 13.2. Connected Cold Chain: Key Tools and Technologies
    • 13.2.1. Artificial Intelligence
    • 13.2.2. Augmented Reality
    • 13.2.3. Automation and Robotics
    • 13.2.4. Big Data Analytics
    • 13.2.5. Block Chain Technology
    • 13.2.6. Cloud Computing
    • 13.2.7. Internet of Things
    • 13.2.8. Radio Frequency Identification (RFID) Tags
  • 13.3. Connected Cold Chain: Future Growth Opportunities
  • 13.4. Real-Time Monitoring: An Application of Connected Cold Chain Solutions
    • 13.4.1 Methods for Integration of Real-Time Monitoring in Cold Chain
      • 13.4.1.1. RFID Based Real-Time Monitoring
      • 13.4.1.2. Blockchain And IoT Based Real-Time Monitoring
    • 13.4.2. Growth Opportunities for Real-Time Monitoring in Connected Cold Chain
    • 13.4.3. Cost Benefits of Real-Time Monitoring in Cold Chain

14. MARKET IMPACT ANALYSIS: DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES

  • 14.1. Chapter Overview
  • 14.2. Market Drivers
  • 14.3. Market Restraints
  • 14.4. Market Opportunities
  • 14.5. Market Challenges
  • 14.6. Conclusion

15. COLD CHAIN MARKET FOR PHARMACEUTICALS

  • 15.1. Chapter Overview
  • 15.2. Assumptions and Methodology
  • 15.3. Global Cold Chain Market for Pharmaceuticals, Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
    • 15.3.1. Scenario Analysis
  • 15.4. Key Market Segmentations
  • 15.5. Dynamic Dashboard

16. COLD CHAIN MARKET FOR PHARMACEUTICALS, BY TYPE OF PRIMARY PACKAGING

  • 16.1. Chapter Overview
  • 16.2. Key Assumptions and Methodology
  • 16.3. Vials: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
  • 16.4. Ampoules: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
  • 16.5. Pre-filled Syringes: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
  • 16.6. Bags: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
  • 16.7. Data Triangulation
    • 16.7.1. Insights from Primary Research
    • 16.7.2. Insights from Secondary Research
    • 16.7.3. Insights from In-house Repository

17. COLD CHAIN MARKET FOR PHARMACEUTICALS, BY TYPE OF SECONDARY PACKAGING

  • 17.1. Chapter Overview
  • 17.2. Key Assumptions and Methodology
  • 17.3. Cold Boxes: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
  • 17.4. Vaccine Carriers: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
  • 17.5. Insulated Containers: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
  • 17.6. Data Triangulation
    • 17.6.1. Insights from Primary Research
    • 17.6.2. Insights from Secondary Research
    • 17.7.3. Insights from In-house Repository

18. COLD CHAIN MARKET FOR PHARMACEUTICALS, BY TYPE OF USABILITY

  • 18.1. Chapter Overview
  • 18.2. Key Assumptions and Methodology
  • 18.3. Reusable Containers / Shippers: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
  • 18.4. Single-use Containers / Shippers: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)

19. COLD CHAIN MARKET FOR PHARMACEUTICALS, BY KEY GEOGRAPHICAL REGIONS

  • 19.1. Chapter Overview
  • 19.2. Key Assumptions and Methodology
  • 19.3. North America: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
  • 19.4. Europe: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
  • 19.5. Asia-Pacific: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
  • 19.6. Middle East and North America: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
  • 19.7. Latin America: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035
  • 19.8. Rest of the World: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
  • 19.9. Data Triangulation
    • 19.9.1. Insights from Primary Research
    • 19.9.2. Insights from Secondary Research
    • 19.9.3. Insights from In-house Repository

20. CONCLUSION

21. EXECUTIVE INSIGHTS

  • 21.1. Chapter Overview
  • 21.2. EMBALL'ISO
    • 21.2.1. Company Snapshot
    • 21.2.2. Interview Transcript
  • 21.3. Tower Cold Chain
    • 21.3.1. Company Snapshot
    • 21.3.2. Interview Transcript

22. APPENDIX 1: TABULATED DATA

23. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS